Page last updated: 2024-08-23

clavulanic acid and 1-methyl-4-phenylpyridinium

clavulanic acid has been researched along with 1-methyl-4-phenylpyridinium in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahn, CH; Kim, DJ; Kost, GC; Lee, YB; Selvaraj, S; Singh, BB	1

Other Studies

1 other study(ies) available for clavulanic acid and 1-methyl-4-phenylpyridinium

Article	Year
Clavulanic acid inhibits MPP⁺-induced ROS generation and subsequent loss of dopaminergic cells. Brain research, 2012, Aug-21, Volume: 1469 Topics: 1-Methyl-4-phenylpyridinium; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspase 9; Cell Line, Tumor; Clavulanic Acid; Cytochromes c; Dopamine; Humans; Membrane Potential, Mitochondrial; Mitochondria; Neurons; Neuroprotective Agents; Reactive Oxygen Species	2012

Article

Year

Clavulanic acid inhibits MPP⁺-induced ROS generation and subsequent loss of dopaminergic cells.

Brain research, 2012, Aug-21, Volume: 1469

Topics: 1-Methyl-4-phenylpyridinium; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspase 9; Cell Line, Tumor; Clavulanic Acid; Cytochromes c; Dopamine; Humans; Membrane Potential, Mitochondrial; Mitochondria; Neurons; Neuroprotective Agents; Reactive Oxygen Species

2012